Schizophrenia and Psychoses

Latest

Predictors of Favorable Outcomes in First-Episode Psychosis Without Medication

Predictors of Favorable Outcomes in First-Episode Psychosis Without Medication

Young patients with first-episode psychosis may be able to achieve recovery.

Schizophrenia Patient Dead After UTI Treatment

Schizophrenia Patient Dead After UTI Treatment

This case offers evidence of the interaction between ciprofloxacin and clozapine.

Mindfulness Intervention Effective for Distressing Voices in Psychosis

Mindfulness Intervention Effective for Distressing Voices in Psychosis

Combined cognitive therapy and mindfulness can have lasting positive effects on behavior and mood.

Underlying Mechanism of Auditory Impairment in Schizophrenia Reveals Potential Therapeutic Path

Underlying Mechanism of Auditory Impairment in Schizophrenia Reveals Potential Therapeutic Path

Benefits of NMDA receptor agonists in patients with schizophrenia include improvements with memory and reading.

No Difference Between Omega-3 & Placebo in Patients at Ultrahigh Risk for Psychosis

No Difference Between Omega-3 & Placebo in Patients at Ultrahigh Risk for Psychosis

PUFA supplementation offers little additional aid to psychosis when good psychosocial care is already sought.

Prolactin-Related Symptoms Decrease with Reduced Risperidone Dosage

Prolactin-Related Symptoms Decrease with Reduced Risperidone Dosage

Hyperprolactinemia should be monitored during long-term risperidone treatment.

Efficacy of Lurasidone Assessed in Adolescents With Schizophrenia

Efficacy of Lurasidone Assessed in Adolescents With Schizophrenia

Sunovion have announced positive results from a study evaluating Latuda (lurasidone HCI) for the treatment of schizophrenia in adolescents aged 13 to 17 years old.

Impaired Auditory 40-Hz Steady-State Responses Noted in Schizophrenia

Impaired Auditory 40-Hz Steady-State Responses Noted in Schizophrenia

40-Hz ASSR spectral power and phase-locking deficits could be useful probes for assessing circuit dysfunctions in the disorder.

Prediabetic Markers May Be Linked With First-Episode Psychosis

Prediabetic Markers May Be Linked With First-Episode Psychosis

The findings might help to explain the increased prevalence of type 2 diabetes in patients with schizophrenia.

Significant Cognitive Impairment in Those At High Risk of Psychosis

Significant Cognitive Impairment in Those At High Risk of Psychosis

Studying cognition deficits during the clinical high risk period allows researchers to observe cognitive defects before chronicity and long-term medication use obscure the core deficits.

Latest Videos

Sign Up for Free e-newsletters